Attached files

file filename
8-K - FORM 8-K - IMMUNE PHARMACEUTICALS INCv399104_8k.htm
EX-99.1 - EXHIBIT 99.1 - IMMUNE PHARMACEUTICALS INCv399104_ex99-1.htm
EX-17.1 - EXHIBIT 17.1 - IMMUNE PHARMACEUTICALS INCv399104_ex17-1.htm
EX-10.1 - EXHIBIT 10.1 - IMMUNE PHARMACEUTICALS INCv399104_ex10-1.htm

 

Exhibit 17.2

January 14, 2015

 

Board of Directors

Immune Pharmaceuticals Inc.

Cambridge Innovation Center

1 Broadway 14th Floor

Cambridge, MA 02142

 

Re:Resignation as a Director of Immune Pharmaceuticals Inc. (the “Company”)

 

Ladies and Gentlemen:

 

Please be advised that I hereby resign my position as a director of the Company, effective January 14, 2015.

 

As agreed, all equity granted to date will be fully vested as of this date January 14, 2015 and the exercise period for all outstanding equity will be extended by two years. In addition, the Company will pay to me no later than by January 19, 2015 fees due of $2,500.

 

I hereby confirm that aside from the items due to me as described above, I have no additional claims, demands or requests from or against the Company, its subsidiaries, affiliates, shareholders, directors or officers, in connection with my service as a director of the Company or resignation from this position.

 

     
    Very truly yours,
     
     
    /s/ Ana Stancic
    Name:  Ana Stancic